The company was established in 2004 under the leadership of personnel studying in the UK, with a registered capital of 360006.1 million yuan. The company is mainly committed to introducing international advanced medical device treatment concepts and technologies into China, specializing in the research and development, production, and sales of medical consumables such as nebulization therapy, humidification therapy, anesthesia breathing pipelines and component connections. Since its establishment, it has applied for 106 patents, including 4 invention patents. It has a certain market share and brand influence in the medical atomizer market，firmly ranking among the top ten brands. In the past two years, it has always ranked second in the ranking of Chinese brand websites, and is on par with world brands such as Omron from Japan, Parry from Germany, Philips from the Netherlands, and major domestic brands such as Yuyue, Benefiting doctors and patients
The company is headquartered in Baotou and has a wholly-owned subsidiary in Dongguan. It mainly operates in a distribution model with a small amount of direct business, as well as an online e-commerce platform. After years of development, the company's products have entered 32 provinces, autonomous regions, and municipalities across the country, forming a nationwide sales and service network
The company has participated in the formulation of technical standards for the registration guidelines of national medical atomizers and mesh atomizers, and is committed to promoting industry development and technological progress. It has won the Silver Award of the State Council Overseas Chinese Entrepreneurship Team and the title of "Top 100 Most Growing Enterprises in China Overseas Chinese Entrepreneurship Park"
The company currently has 281 employees and has passed ISO13485 system certification and intellectual property system certification. It has 10 Class II medical device registration certificates and 11 Class I medical device registration certificates. Design products have won honorary awards such as the "China Design Red Star Award" and the "China Excellent Industrial Design Award Finalist Qualification". In 2014, it was recognized as the Engineering Research Center of the Autonomous Region Development and Reform Commission, in 2015, it was recognized as the Enterprise Technology Center of the Autonomous Region Economic and Information Technology Commission, in 2015, it was recognized as the Engineering Technology Research Center of the Autonomous Region Science and Technology Department, and in 2022, it was rated as a "technology-based small and medium-sized enterprise" and a specialized, refined, and new enterprise in Inner Mongolia Autonomous Region
The company was listed in the New Third Edition in 2017 and was promoted from the basic level to the innovation level in 2020
In 2022, the company invested 50 million yuan to expand the plant, with a building area of 19500m2, built three automatic production lines, mainly producing nebulizer and breathing tubes, which are expected to be put into production in October 2023. After the new project is put into operation, the production capacity of the company will increase to 300 million yuan
